论文部分内容阅读
近年,美欧国家为了控制保健费用正大力推动非专利药市场的发展。2003年12月17日,欧洲议会通过了新药立法。2003年8月19日,美国新的FDA法规实施以加速非专利药的上市。我国医药中间体和原料药生产企业应引起重视。
In recent years, the United States and Europe are vigorously promoting the development of the generic drug market in order to control the cost of health care. On December 17, 2003, the European Parliament passed the new drug legislation. August 19, 2003, the United States to implement the new FDA regulations to accelerate the listing of generic drugs. China’s pharmaceutical intermediates and raw materials drug manufacturers should pay attention.